| http://www.w3.org/ns/prov#value | - Merck is advancing a broad and fast-growing clinical development program for KEYTRUDA with more than 85 clinical trials ??? across more than 30 tumor types and over 14,000 patients ??? both as a monotherapy and in combination with other therapies.???
|
